Do Americans hate science? They certainly seem to hate it more than they used to, as they rage against experts in every field. This is more than a traditional American distaste for eggheads and intellectuals. Americans, increasingly, are acting (and voting) on myths and misinformation about science, and placing themselves at significant risk. In Texas, for example, “personal-belief exemptions” among…
Read More
A private biotechnology company developing state-of-the-art lipid nanoparticle (LNP) delivery technology for messenger RNA (mRNA), announced today publication of data demonstrating that mRNA encoding a broadly neutralizing antibody delivered in an Acuitas LNP carrier protects humanized mice from HIV-1 challenge. In a paper published today in Nature Communications, Acuitas’ scientists and academic researchers lead by Drew Weissman, MD, PhD, a professor…
Read More
ABSTRACT: CDC-like kinase phosphorylation of serine/arginine-rich proteins is central to RNA splicing reactions. Yet, the genomic network of CDC-like kinase-dependent RNA processing events remains poorly defined. Here, we explore the connectivity of genomic CDC-like kinase splicing functions by applying graduated, short-exposure, pharmacological CDC-like kinase inhibition using a novel small molecule (T3) with very high potency, selectivity, and cell-based stability. Using…
Read More
B.C.’s innovation-driven biotech leaders are stepping on to the world stage and generating $14.4 billion a year in economic effect in the process. Vancouver-based Stemcell Technologies, for example, has emerged as a global presence with customer support and distribution hubs in Canada, the United States, Europe, Asia and Australia, and annual revenues reportedly topping $150 million. But as impressive as that figure sounds — and…
Read More
This past summer, the future of our postdoctoral association’s Science Policy Committee was uncertain. We were without purpose, our programming was sporadic—a seminar here, a blog post there—and overall interest seemed low. As a co-chair of the committee, which had dwindled to a grand total of two members, I struggled to identify ways to engage our postdoc community and to transform…
Read More
On a drizzly mid-week evening downtown, beer glasses clink as a roomful of people sit, eyes fixed to a slideshow of complicated-looking graphs. The professor leading the presentation – on anything from prehistoric megafauna to advances in robotic engineering – speaks candidly, occasionally drawing a gasp from the awe-struck crowd. The popular science scene in Vancouver has been growing steadily…
Read More
Dr. Corey Nislow is an associate professor in the Faculty of Pharmaceutical Sciences at UBC. His research combines biotechnology and genomics to address fundamental questions about the link between environment and gene function. This includes a collaboration with NASA  examining the effects of microgravity and radiation on yeast cells by sending them to space. We sat down with Dr. Nislow…
Read More
The Alzheimer Society of B.C. and UBC celebrated a decade-long partnership in maintaining the Ralph Fisher and Alzheimer Society of B.C. Professorship in Alzheimer Disease Research earlier this week and welcomed Dr. Robin Hsiung, who was recently awarded the Professorship. “We are so proud of our partnership with UBC and the role the Professorship has played in supporting world-class scientists…
Read More
The initial stages of a PhD can be daunting. Fortunately, there are a few ways you can make the transition into productive doctoral study as smooth as possible. Whether you’re starting a PhD fresh out of undergrad or after many years of employment, the decision to begin a doctorate is a significant career move. When I started, 18 months ago,…
Read More